Biofermin Pharmaceutical. (4517.TSE) Q4 2017 Earnings

31JanExpected
Q1 2017
Q2 2017
Q3 2017
Q4 2017
22.28
37.15
52.03
66.9

Details

Expected EPS
N/A
Actual EPS
39.9969
Surprise EPS
40
Surprise Percent
+∞%

Description

Biofermin Pharmaceutical. (4517.TSE) has reported earnings of 39.9969 per share for Q4 2017.

0 Comments

Share your thoughts